PRESS RELEASE published on 06/24/2024 at 23:00, 1 year 5 months ago Medicure Announces Signing of Asset Purchase Agreement with CanAm Bioresearch Inc. for Acquisition of Intellectual Property Medicure Inc. announces asset purchase agreement with CanAm Bioresearch for acquisition of patent and intellectual property related to new chemical entities for therapeutic use Medicure Inc. Asset Purchase Agreement CanAm Bioresearch New Chemical Entities Therapeutic Use
BRIEF published on 05/28/2024 at 23:05, 1 year 6 months ago Medicure Reports Financial Results for Q1 2024 and Director Election Results Financial Results Director Election Q1 2024 Medicure
BRIEF published on 05/28/2024 at 23:05, 1 year 6 months ago Medicure publie ses résultats financiers pour le premier trimestre 2024 et les résultats de l'élection des administrateurs Résultats Financiers Médicament T1 2024 Élection Du Directeur
PRESS RELEASE published on 05/28/2024 at 23:00, 1 year 6 months ago Medicure Reports Financial Results for Quarter Ended March 31, 2024 and Annual General Meeting Director Election Results Medicure Inc. reports Q1 2024 financial results and director elections. Total revenue slightly up, AGGRASTAT® revenue down. Adjusted EBITDA decreased. New director appointed Revenue Medicure Inc. Director Elections Q1 2024 Financial Results AGGRASTAT®
BRIEF published on 04/23/2024 at 23:05, 1 year 7 months ago Medicure reçoit la désignation Fast Track de la FDA pour le traitement MC-1 du déficit en PNPO Medicure Inc. Désignation De Médicament Orphelin Désignation Fast Track De La FDA MC-1 Carence En PNPO
BRIEF published on 04/23/2024 at 23:05, 1 year 7 months ago Medicure Receives FDA Fast Track Designation for MC-1 Treatment for PNPO Deficiency Medicure Inc. Orphan Drug Designation FDA Fast Track Designation MC-1 PNPO Deficiency
PRESS RELEASE published on 04/23/2024 at 23:00, 1 year 7 months ago Medicure Receives US FDA Fast Track Designation for MC-1 for PNPO Deficiency Medicure Inc. receives FDA Fast Track designation for MC-1 to treat PNPO deficiency seizures, a serious condition. Rare Pediatric Disease and Orphan Drug designations granted Medicure Inc. Orphan Drug Designation FDA Fast Track Designation MC-1 PNPO Deficiency Seizures
BRIEF published on 04/08/2024 at 23:05, 1 year 7 months ago Medicure Inc. réfléchit à son exercice 2023 et à ses performances au quatrième trimestre Résultats Financiers Médicament Industrie Pharmaceutique AGGRASTAT ZYPITAMAG
BRIEF published on 04/08/2024 at 23:05, 1 year 7 months ago Medicure Inc. Reflects on its 2023 Financial Year and Q4 Performance Financial Results Pharmaceutical Industry Medicure AGGRASTAT ZYPITAMAG
PRESS RELEASE published on 04/08/2024 at 23:00, 1 year 7 months ago Medicure Reports Financial Results for Quarter and Year Ended December 31, 2023 Medicure Inc. reports results from operations for the quarter and year ended December 31, 2023. Net revenue, EBITDA, and financial highlights disclosed Financial Results EBITDA Quarterly Report Medicure Inc. Revenue Analysis
Published on 12/05/2025 at 02:35, 10 hours 36 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 12 hours 11 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 14 hours 6 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 14 hours 11 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 13:00, 11 minutes ago Zentra Group plc: Posting of Notice of Annual General Meeting
Published on 12/05/2025 at 13:00, 11 minutes ago Form 8.3 - Zürcher Kantonalbank: Cicor Technologies Ltd.
Published on 12/05/2025 at 12:05, 1 hour 6 minutes ago Cango Inc. Announces November 2025 Bitcoin Production and Mining Operations Update
Published on 12/05/2025 at 12:00, 1 hour 11 minutes ago CGTN:Strengthening cultural ties: Peng Liyuan, Brigitte Macron visit Beijing People's Art Theatre
Published on 12/05/2025 at 12:00, 1 hour 11 minutes ago Iute Group: Successful Issue of Additional EUR 2025/2030 Bonds – Circulating Volume Increased to EUR 160 Million
Published on 12/05/2025 at 08:45, 4 hours 26 minutes ago Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 4 hours 26 minutes ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/05/2025 at 08:42, 4 hours 29 minutes ago ENGIE - déclaration mensuelle du nombre total d'actions et de droits de vote composant le capital au 30 novembre 2025
Published on 12/04/2025 at 18:14, 18 hours 57 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 19 hours 11 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025